🇪🇺 BCD-066 in European Union

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EMA authorised BCD-066 on 8 June 2001

Marketing authorisation

EMA — authorised 8 June 2001

Application: EMEA/H/C/000333
Marketing authorisation holder: Dompé Biotec S.p.A.
Local brand name: Nespo
Indication: Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients.Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Status: withdrawn

Read official source →

Frequently asked questions

Is BCD-066 approved in European Union?

Yes. EMA authorised it on 8 June 2001.

Who is the marketing authorisation holder for BCD-066 in European Union?

Dompé Biotec S.p.A. holds the EU marketing authorisation.